Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    SUPAC Guidances to Get an Update - Lachman Blog

    SUPAC Guidances to Get an Update?

    In today’s Federal Notice pre-publication page (here), the FDA is re...
    Read More
    FDA Headquarters

    FDA Commissioner Makary Indicates Compounding Crackdown

    Dr. Makary has indicated that the FDA will take an aggressive enforcem...
    Read More
    Day 2 Highlights at AAM Access 2026 - Lachman Blog

    Day 2 Highlights at AAM Access 2026

    The newly named Board Chair of the Association of Accessible Medicines...
    Read More
    98 New and Revised PSGs Issued Today - Lachman Blog

    98 New and Revised PSGs Issued Today

    Today, the Office of Generic Drugs announced the issuance of 98 Produc...
    Read More
    Access 2026 Meeting More from Day One - Lachman Blog

    Access 2026 Meeting: More from Day One

    The Association of Accessible Medicines (AAM) continued Day 1 with a...
    Read More
    Businessman Addressing Delegates At Conference

    AAM Annual Meeting Access 2026: Some Highlights

    John Murphy III, CEO of the Association of Accessible Medicines (AAM),...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today